Vanguard Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $12.4B | Buy |
128,961,343
+1,888,381
| +1% | +$183M | 0.18% | 92 |
|
|
2025
Q3 | $12.1B | Buy |
127,072,962
+163,556
| +0.1% | +$15M | 0.18% | 95 |
|
|
2025
Q2 | $11.1B | Buy |
126,909,406
+1,895,165
| +2% | +$161M | 0.18% | 96 |
|
|
2025
Q1 | $11.2B | Buy |
125,014,241
+810,854
| +0.7% | +$72.6M | 0.2% | 85 |
|
|
2024
Q4 | $9.92B | Buy |
124,203,387
+754,395
| +0.6% | +$65.3M | 0.17% | 96 |
|
|
2024
Q3 | $11.1B | Sell |
123,448,992
-3,158,079
| -2% | -$266M | 0.2% | 83 |
|
|
2024
Q2 | $9.97B | Buy |
126,607,071
+323,738
| +0.3% | +$26.5M | 0.19% | 90 |
|
|
2024
Q1 | $11B | Sell |
126,283,333
-264,723
| -0.2% | -$22.6M | 0.22% | 75 |
|
|
2023
Q4 | $10.4B | Buy |
126,548,056
+438,864
| +0.3% | +$33.4M | 0.23% | 72 |
|
|
2023
Q3 | $9.88B | Buy |
126,109,192
+267,821
| +0.2% | +$22.4M | 0.24% | 66 |
|
|
2023
Q2 | $11.1B | Buy |
125,841,371
+206,692
| +0.2% | +$17.8M | 0.26% | 63 |
|
|
2023
Q1 | $10.1B | Buy |
125,634,679
+507,977
| +0.4% | +$41.4M | 0.26% | 67 |
|
|
2022
Q4 | $9.72B | Buy |
125,126,702
+1,264,708
| +1% | +$103M | 0.26% | 68 |
|
|
2022
Q3 | $10B | Buy |
123,861,994
+1,056,995
| +0.9% | +$95M | 0.29% | 56 |
|
|
2022
Q2 | $11B | Buy |
122,804,999
+2,247,511
| +2% | +$228M | 0.31% | 55 |
|
|
2022
Q1 | $13.4B | Buy |
120,557,488
+7,403,778
| +7% | +$782M | 0.32% | 54 |
|
|
2021
Q4 | $11.7B | Buy |
113,153,710
+654,088
| +0.6% | +$75.7M | 0.27% | 60 |
|
|
2021
Q3 | $14.1B | Buy |
112,499,622
+720,332
| +0.6% | +$93.2M | 0.35% | 48 |
|
|
2021
Q2 | $13.9B | Buy |
111,779,290
+717,126
| +0.6% | +$90M | 0.35% | 48 |
|
|
2021
Q1 | $13.1B | Sell |
111,062,164
-223,854
| -0.2% | -$26.2M | 0.35% | 46 |
|
|
2020
Q4 | $13B | Sell |
111,286,018
-589,565
| -0.5% | -$64.9M | 0.38% | 47 |
|
|
2020
Q3 | $11.6B | Sell |
111,875,583
-1,237,067
| -1% | -$124M | 0.38% | 49 |
|
|
2020
Q2 | $10.4B | Sell |
113,112,650
-4,622,375
| -4% | -$443M | 0.37% | 49 |
|
|
2020
Q1 | $10.6B | Buy |
117,735,025
+3,117,546
| +3% | +$332M | 0.45% | 39 |
|
|
2019
Q4 | $13B | Buy |
114,617,479
+1,106,561
| +1% | +$121M | 0.44% | 36 |
|
|
2019
Q3 | $12.3B | Buy |
113,510,918
+1,176,633
| +1% | +$123M | 0.46% | 35 |
|
|
2019
Q2 | $10.9B | Buy |
112,334,285
+640,083
| +0.6% | +$58.4M | 0.41% | 37 |
|
|
2019
Q1 | $10.2B | Sell |
111,694,202
-288,974
| -0.3% | -$25.9M | 0.4% | 39 |
|
|
2018
Q4 | $10.2B | Buy |
111,983,176
+2,535,489
| +2% | +$237M | 0.46% | 34 |
|
|
2018
Q3 | $10.8B | Buy |
109,447,687
+1,199,118
| +1% | +$111M | 0.42% | 37 |
|
|
2018
Q2 | $9.27B | Buy |
108,248,569
+1,279,249
| +1% | +$107M | 0.39% | 41 |
|
|
2018
Q1 | $8.58B | Buy |
106,969,320
+43,572
| +0% | +$3.59M | 0.38% | 43 |
|
|
2017
Q4 | $8.63B | Buy |
106,925,748
+1,438,726
| +1% | +$115M | 0.38% | 43 |
|
|
2017
Q3 | $8.2B | Buy |
105,487,022
+710,986
| +0.7% | +$59M | 0.38% | 42 |
|
|
2017
Q2 | $9.3B | Buy |
104,776,036
+2,454,380
| +2% | +$207M | 0.46% | 35 |
|
|
2017
Q1 | $8.24B | Buy |
102,321,656
+4,412,536
| +5% | +$345M | 0.42% | 36 |
|
|
2016
Q4 | $6.97B | Buy |
97,909,120
+1,010,412
| +1% | +$79.4M | 0.39% | 40 |
|
|
2016
Q3 | $8.37B | Buy |
96,898,708
+1,221,005
| +1% | +$106M | 0.49% | 31 |
|
|
2016
Q2 | $8.3B | Buy |
95,677,703
+1,489,823
| +2% | +$120M | 0.52% | 31 |
|
|
2016
Q1 | $7.06B | Buy |
94,187,880
+4,448,206
| +5% | +$335M | 0.46% | 37 |
|
|
2015
Q4 | $6.9B | Buy |
89,739,674
+2,935,600
| +3% | +$221M | 0.46% | 37 |
|
|
2015
Q3 | $5.81B | Buy |
86,804,074
+463,528
| +0.5% | +$34.1M | 0.42% | 40 |
|
|
2015
Q2 | $6.4B | Buy |
86,340,546
+863,771
| +1% | +$66M | 0.43% | 42 |
|
|
2015
Q1 | $6.67B | Buy |
85,476,775
+27,156,460
| +47% | +$2.06B | 0.45% | 38 |
|
|
2014
Q4 | $4.21B | Buy |
58,320,315
+1,649,756
| +3% | +$115M | 0.3% | 53 |
|
|
2014
Q3 | $3.51B | Buy |
56,670,559
+142,435
| +0.3% | +$9.06M | 0.27% | 62 |
|
|
2014
Q2 | $3.6B | Buy |
56,528,124
+637,061
| +1% | +$38.7M | 0.28% | 59 |
|
|
2014
Q1 | $3.44B | Buy |
55,891,063
+933,209
| +2% | +$54.4M | 0.29% | 57 |
|
|
2013
Q4 | $3.15B | Buy |
54,957,854
+980,556
| +2% | +$55.6M | 0.28% | 63 |
|
|
2013
Q3 | $2.87B | Buy |
53,977,298
+551,848
| +1% | +$29.7M | 0.28% | 64 |
|
|
2013
Q2 | $2.75B | Buy |
+53,425,450
| New | +$2.64B | 0.29% | 62 |
|
Other funds holding MDT
Vanguard Group's MDT Position: Q4 2025 in Review
Vanguard Group increased its Medtronic (MDT) stake by 1.5% in Q4 2025, buying an estimated $183M and bringing the position to 128,961,343 shares worth $12.4B. The position accounts for 0.18% of the portfolio, ranked #92.
Vanguard Group first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $14.1B in Q3 2021. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.
- Vanguard Group held 128,961,343 shares of Medtronic worth $12.4B as of Q4 2025.
- Vanguard Group bought 1,888,381 Medtronic shares in Q4 2025, an estimated $183M.
- Medtronic made up 0.18% of Vanguard Group's portfolio in Q4 2025, its #92 holding.
- Vanguard Group first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Medtronic position peaked at $14.1B in Q3 2021.
- 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.